Patents by Inventor Warren Galloway

Warren Galloway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF
    Publication number: 20260193180
    Abstract: The present invention relates to compounds of formula (I) or a salt, stereoisomer, tautomer or N-oxide thereof. Furthermore, the present invention relates to compounds of formula (I), or a salt, stereoisomer, tautomer or N-oxide thereof, which are suitable for inducing and/or stimulating the process of autophagy, as well as compounds of formula (I) for use in medicine and the treatment of autophagy related diseases or disorders.
    Type: Application
    Filed: November 14, 2023
    Publication date: July 9, 2026
    Inventors: Peter Hamley, Warren Galloway, Ben Atkinson
  • AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS
    Publication number: 20250049776
    Abstract: The invention relates to pharmaceutical compositions and methods of treating autophagy related diseases and disorders, in particular for a systemic treatment thereof. The present invention relates to compounds according to Formula (I) or salts, solvates and/or hydrates thereof, wherein said compounds induce and/or stimulate the process of autophagy, as well as uses of the compounds in the treatment and prevention of autophagy related diseases and disorders. Examples are cancer, age-related diseases, and viral infection that can be effectively treated with compounds that are effective when provided systemically.
    Type: Application
    Filed: November 17, 2022
    Publication date: February 13, 2025
    Inventors: Peter Hamley, Warren Galloway, Oliver Kepp, Guido Kroemer
  • AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR DISEASES OF THE CNS
    Publication number: 20250034127
    Abstract: The invention relates to pharmaceutical compositions and methods of treating autophagy related diseases and disorders, and in particular neurological and/or CNS-related diseases. The present invention relates to compounds according to Formula (I) or salts, solvates and/or hydrates thereof, wherein said compounds induce and/or stimulate the process of autophagy, as well as uses of the compounds in the treatment and prevention of autophagy related diseases and disorders. Examples are cancer, age-related diseases, and viral infection, in particular of the CNS.
    Type: Application
    Filed: November 17, 2022
    Publication date: January 30, 2025
    Inventors: Peter Hamley, Warren Galloway, Oliver Kepp, Guido Kroemer